DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy (Q84630032)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Dairong Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Qi Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yu Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yanqing Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Qiying Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

31 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1622-1628

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21805378%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12032-011-0033-7

9 February 2020

exact match

0 references

cites work

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy

1 reference

12 December 2020

Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.

1 reference

12 December 2020

Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population

1 reference

12 December 2020

Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene

1 reference

12 December 2020

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

1 reference

12 December 2020

Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis

1 reference

12 December 2020

Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients

1 reference

12 December 2020

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

12 December 2020

ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy

1 reference

12 December 2020

Quality control by DNA repair

1 reference

12 December 2020

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

1 reference

12 December 2020

The pharmacogenetics research network: from SNP discovery to clinical drug response.

1 reference

12 December 2020

Pharmacogenomics of platinum-based chemotherapy in NSCLC

1 reference

12 December 2020

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

1 reference

12 December 2020

ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review

1 reference

12 December 2020

Molecular mechanisms involved in cisplatin cytotoxicity.

1 reference

12 December 2020

[Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer]

1 reference

12 December 2020

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

12 December 2020

Preclinical perspectives on platinum resistance

1 reference

12 December 2020

Molecular mechanism of nucleotide excision repair.

1 reference

12 December 2020

RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.

1 reference

12 December 2020

Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review

1 reference

12 December 2020

Genetic effect of ERCC1 codon 118 polymorphism and confounding factors

1 reference

12 December 2020

ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer

1 reference

12 December 2020

Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin.

1 reference

12 December 2020

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

1 reference

12 December 2020

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.

1 reference

12 December 2020

[Correlation of genetic polymorphisms in nucleotide excision repair system to sensitivity of advanced non-small cell lung cancer patients to platinum-based chemotherapy]

1 reference

12 December 2020

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

1 reference

12 December 2020

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

1 reference

12 December 2020

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

1 reference

12 December 2020

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

1 reference

12 December 2020

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

1 reference

12 December 2020

Polymorphisms in XRCC1, XRCC3, and CCND1 and survival after treatment for metastatic breast cancer.

1 reference

12 December 2020

Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.

1 reference

12 December 2020